Synthesis and Structure–Activity Relationships of<i>N</i>-Benzyl Phenethylamines as 5-HT<sub>2A/2C</sub>AgonistsMartin Hansen, Jesper L. Kristensen, Karina Phonekeo et al.|ACS Chemical Neuroscience|2014Cited by 125
Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of N-(2-Hydroxybenzyl)-2,5-Dimethoxy-4-Cyanophenylethylamine (25CN-NBOH), a Highly Selective and Brain-Penetrant 5-HT2A Receptor AgonistAnders A. Jensen, Jesper L. Kristensen, Jan Kehler et al.|Journal of Pharmacology and Experimental Therapeutics|2017Cited by 62
Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A/2C partial agonistsMartin Hansen, Jesper L. Kristensen, Shane Plunkett et al.|Bioorganic & Medicinal Chemistry|2014Cited by 35
Tweaking Agonist Efficacy at N-Methyl-d-aspartate Receptors by Site-Directed MutagenesisKasper B. Hansen, Hans Bräuner‐Osborne, Rasmus P. Clausen et al.|Molecular Pharmacology|2005Cited by 28
The selective 5-HT2A receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOHAnders A. Jensen, Jesper L. Kristensen, Adam L. Halberstadt et al.|Biochemical Pharmacology|2020Cited by 25